1、Ouyang S, Gong B, Li JZ, Zhao LX, Wu W, Zhang FS, Sun L, Wang SJ, Pan M, Li C, Liang W, Shaw N, Zheng J, Zhao GP, Wang Y#, Liu ZJ, Liang M. Structural insights into a human anti-IFN antibody exerting therapeutic potential for systemic lupus erythematosus. J Mol Med (Berl),2012;90(7):837-46
2、刘芝翠,王树军,曾维宏,张勇,沈浩,王颖#. 人T细胞活化促进B细胞抗体产生机制的体外研究. 现代免疫学,2012;32（6）：450-456
3、Meriem Boukherouba（梅瑞安）,王树军,刘芝翠,李金枝,张勇,潘萌,王颖#. I型干扰素参与调节系统性红斑狼疮中外周T细胞活化和TLRs分子表达谱格局的研究. 现代免疫学,2012;32（5）：353-358
4、吴标,赵国屏,王颖#. 胞内抗体研究进展及临床应用前景. 现代免疫学,2012;32（4）：343-347
5、夏立亮,吴标, 程亚庭, 包文静, 赵国屏,王颖#. 抗H5N1禽流感病毒羊驼重链单域抗体的制备和功能鉴定. 中国免疫学,2012;28(2)：137-141
6、夏立亮 ,吴标, 程亚庭,蔡家麟,赵国屏,王颖#. 羊驼抗H5N1血凝素重链可变区-人IgGFc段嵌合抗体的制备和鉴定 . 新代免疫学,2012;32(1)：19-24
7、He M, Wang Y, Shi WJ, Wang SJ, Sha HF, Feng JX, Wang J. Immunomodulation of inducible co-stimulator (ICOS) in human cytokine-induced killer cells against cholangiocarcinoma through ICOS/ICOS ligand interaction. J Dig Dis,2011;12(5):393-400
8、严安,孙冰云,夏立亮,吴标,包文静,车小燕,孙志伟,金维荣,赵国屏,熊慧,王颖#. 抗H5N1禽流感病毒VHH抗体库的构建. 中国免疫学,2011;27(1)：44-49
9、吴标,王树军,夏立亮,季萍,葛海良,赵国屏,王颖#. 羊驼非免疫重链单域抗体库的构建和鉴定. 现代免疫学,2011;31(5)：353-357
10、李金枝,丁隽,李昊文,张勇,沈浩,陈学进,王树军,王颖#. Pristance 诱导小鼠系统性红斑狼疮动物模型的研究. 细胞与分子免疫学杂志,2011;27(2)：119-121
11、顾卓伟,狄文,叶薇怡,王颖 #. IDo和 FoxP3 表达与宫颈癌发生和病理进程的相关性. 上海交通大学学报（医学版）,2011;(5):604-609
12、顾卓伟,狄文,叶薇怡,王颖#. 吲哚胺2,3双加氧酶在妇科肿瘤免疫耐受中的作用. 中国妇幼健康研究,2011;22(1)：121-123
13、Wu X, Feng QM, Wang Y, Shi J, Ge HL, Di W. The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy. Cancer Immunol Immunother,2010;59(2):279-91
14、Wang J, He M, Shi W, Sha H, Feng J, Wang S, Wang Y. Inducible costimulator (ICOS) enhances the cytolytic activity of cytokine-induced killer cells against gallbladder cancer in vitro and in vivo. Cancer Invest,2009;27(3):244-50
15、Mingueneau M, Roncagalli R, Gregoire C, Kissenpfennig A, Miazek A, Archambaud C, Wang Y, Perrin P, Bertosio E, Sansoni A, Richelme S, Locksley RM, Aguado E, Malissen M, Malissen B. Loss of the LAT adaptor converts antigen-responsive T cells into pathogenic effectors that function independently of the T cell receptor.. Immunity,2009;31(2):197-208
16、Wang Y, Kissenpfennig A, Mingueneau M, Richelme S, Perrin P, Chevrier S, Genton C, Lucas B, DiSanto JP, Acha-Orbea H, Malissen B, Malissen M. Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cells. J Immunol,2008;180(3):1565-75
17、Wang Q, Li M, Wang Y, Zhang Y, Jin S, Xie G, Liu Z, Wang S, Zhang H, Shen L, Ge H. RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells. Cancer Lett,2008;269(1):127-38
18、Jin S, Wang Y#, Zhang Y, Zhang HZ, Wang SJ, Tang JQ, Chen HJ, Ge HL. Humoral immune responses against tumor-associated antigen OVA66 originally defined by serological analysis of recombinant cDNA expression libraries and its potentiality in cellular immunity. Cancer Sci,2008;99(8):1670-8
19、Gregoire C, Simova S, Wang Y, Sansoni A, Richelme S, Schmidt-Giese A, Simeoni L, Angelisova P, Reinhold D, Schraven B, Horejsi V, Malissen B, Malissen M. Deletion of the LIME adaptor protein minimally affects T and B cell development and function. Eur J Immunol,2007;37(11):3259-69
|
